Filgrastim pharmacokinetics
WebNov 11, 2024 · Pharmacokinetics. Filgrastim products exhibit nonlinear pharmacokinetics. Clearance is dependent on filgrastim product concentration and neutrophil count: G-CSF receptor-mediated clearance is saturated by high concentration of filgrastim products and is diminished by neutropenia. In addition, filgrastim products … WebUses. Filgrastim is a man-made version of a certain natural substance made by your body. It is used to help your body make more white blood cells. White blood cells are important …
Filgrastim pharmacokinetics
Did you know?
WebJun 2, 2024 · Filgrastim is a water-soluble 175 amino acid protein with a molecular weight of approximately 19 kilodaltons (kD). Filgrastim is obtained from the bacterial fermentation of a strain of E coli transformed with a genetically engineered plasmid containing the human G … WebPharmacokinetics: Rapid distribution after injection, excreted by kidneys Contraindications: Interleukins Contraindications: Known allergy, renal/liver/CV impairment, CNS disorders, pregnancy Adverse effects: Interleukins Adverse effects: Lethargy, myalgia, arthralgia, fatigue, fever, respiratory difficulties, depression with suicidal ideation
WebUDENYCA is contraindicated in patients with a history of serious allergic reactions to pegfilgrastim products or filgrastim products. ... The pharmacokinetics and safety of pegfilgrastim were studied in 37 pediatric patients with sarcoma in Study 4 [see Clinical Studies 14.1]. The mean (± standard deviation [SD]) systemic exposure (AUC 0-inf ... WebNov 1, 2012 · Receiving filgrastim at 5mcg/kg ± 10% Admitted as an inpatient with an expected stay of at least 24 hours Weight is > 190% of their ideal body weight (IBW) for "obese" patients or within 80 - 124% of IBW for matched control patients.
Webfrom bone marrow storage pools and reduces their maturation time. Filgrastim acts to increase the phagocytic activity of mature neutrophils. In patients receiving cytotoxic … WebNational Center for Biotechnology Information
WebJul 4, 2024 · The principal aim of filgrastim is to reduce the incidence of infection manifested by febrile neutropenia in patients receiving myelosuppressive chemotherapy. Thus, being alert to signs of infection would guide dosage and improve response outcomes in these patients.
Webadministration containing filgrastim at a specific activity of 1.0 ± 0.6 x 10 8 U/mg (as measured by a cell mitogenesis assay). The product is available in single-use vials and … is albumin part of bmpWebFilgrastim is approved to reduce the chance of infection in patients with: Neutropenia caused by some types of chemotherapy, including: Chemotherapy for acute myeloid … is albumin syntheticWebPatients with Severe Chronic Neutropenia. NEUPOGEN is indicated for chronic administration to reduce the incidence and duration of sequelae of severe neutropenia … olive and citrus redlandsWebNov 1, 2024 · The objective of this study was to compare filgrastim pharmacokinetic parameters for morbidly obese and non-obese patients after a single subcutaneous dose … is albumin level of 2.8 lowWeb22 Filgrastim and pegfilgrastim have the same mechanism of action. Pegfilgrastim has 23 reduced renal clearance and prolonged persistence in vivo as compared to Filgrastim. 24 Pharmacokinetics The pharmacokinetics and pharmacodynamics of Neulasta 25 were studied in 379 patients 26 with cancer. The pharmacokinetics of Neulasta were … olive and clovis aveWebSep 12, 2013 · The primary objective of this study is to find the optimal dose of balugrastim by characterizing its pharmacokinetics (PK), and by comparing the pharmacodynamics (PD) of balugrastim to filgrastim in children receiving chemotherapy. Study Design Go to Resource links provided by the National Library of Medicine olive and blue cheese dipWebJul 4, 2024 · National Center for Biotechnology Information olive and co candles